These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6889965)

  • 21. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
    Anger K; Möller T; Zeimantz E
    Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastasis to the sternum or parasternal recurrence of breast carcinoma? Value of sonography].
    Mende U; Huober J; Schmid H; Winterbauer T; Bastert G; Wannenmacher M
    Radiologe; 1996 Jan; 36(1):22-30. PubMed ID: 8820368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer.
    Wakasugi S; Tsukuma H; Inaji H; Hashizume T; Noguchi A; Ohnishi T
    Ann Nucl Med; 2007 Oct; 21(8):429-37. PubMed ID: 17952551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancer.
    McKillop JH; Blumgart LH; Wood CB; Fogelman I; Furnival CM; Greig WR; Citrin DL
    Br J Surg; 1978 Sep; 65(9):649-52. PubMed ID: 698540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of bone scans in the management of patients with carcinoma of the breast.
    Burkett FE; Scanlon EF; Garces RM; Khandekar JD
    Surg Gynecol Obstet; 1979 Oct; 149(4):523-5. PubMed ID: 483128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up.
    Rosselli Del Turco M; Palli D; Cariddi A; Ciatto S; Pacini P; Distante V
    JAMA; 1994 May; 271(20):1593-7. PubMed ID: 7848404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone scintigrams: their clinical usefulness in patients with breast carcinoma.
    Joo KG; Parthasarathy KL; Bakshi SP; Rosner D
    Oncology; 1979; 36(2):94-8. PubMed ID: 460790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal scintigraphy in the inital assessment of women with breast cancer.
    Lindholm A; Lundell L; Mårtenson B; Thulin A
    Acta Chir Scand; 1979; 145(2):65-71. PubMed ID: 463441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of initial and follow-up bone scans in patients with operable breast cancer.
    Coker DD; Lambrecht RW; Kehn BD
    Mil Med; 1980 Jul; 145(7):492-4. PubMed ID: 6772993
    [No Abstract]   [Full Text] [Related]  

  • 30. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
    Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
    J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.
    Nicolini A; Ferrari P; Sagripanti A; Carpi A
    Br J Cancer; 1999 Mar; 79(9-10):1443-7. PubMed ID: 10188888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging investigations in patients with breast cancer: the role of bone scans and liver imaging.
    Samant R; Ganguly P
    Arch Surg; 1999 May; 134(5):551-3; discussion 554. PubMed ID: 10323429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging breast cancer: role of bone scanning.
    Davies CJ; Griffiths PA; Preston BJ; Morris AH; Elston CW; Blamey RW
    Br Med J; 1977 Sep; 2(6087):603-5. PubMed ID: 901997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of the 99Tcm phosphate bone scan to the study of breast cancer.
    Citrin DL; Bessent RG; Greig WR; McKellar NJ; Furnival C; Blumgart LH
    Br J Surg; 1975 Mar; 62(3):201-4. PubMed ID: 1122358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy.
    Arnstein NB; Harbert JC; Byrne PJ
    Cancer; 1984 Nov; 54(10):2243-7. PubMed ID: 6488143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline staging tests in primary breast cancer: a practice guideline.
    Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
    CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of pretreatment clinical and biochemical parameters in patients with newly diagnosed untreated prostate carcinoma and no indications for bone metastases on the bone scintigram.
    Stokkel M; Zwinderman A; Zwartendijk J; Pauwels E; van Eck-Smit B
    Eur J Nucl Med; 1997 Oct; 24(10):1215-20. PubMed ID: 9323261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of serial bone scanning in operable breast cancer.
    Monypenny IJ; Grieve RJ; Howell A; Morrison JM
    Br J Surg; 1984 Jun; 71(6):466-8. PubMed ID: 6722488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of skeletal scintigraphy in the follow-up of breast cancer].
    Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
    Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radionuclide evaluation of skeletal metastases: practical considerations.
    Gold RH; Bassett LW
    Skeletal Radiol; 1986; 15(1):1-9. PubMed ID: 3941915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.